SCHEMBL104278

SCHEMBL104278

C=C1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15284933 1.00 TRIM24 (0.38)
SCHEMBL8763986 1.00 TRIM24 (0.38)
SCHEMBL7138204 1.00 TRIM24 (0.38)
SCHEMBL1635045 1.00
SCHEMBL2221624 1.00 TRIM24 (0.38)
SCHEMBL7065109 1.00 TRIM24 (0.38)
SCHEMBL2221659 1.00 TRIM24 (0.38)
SCHEMBL100582 1.00
SCHEMBL9292166 1.00
SCHEMBL101997 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117886814-A PD-1/PD-L1 small molecule inhibitor and application thereof in medicines 广东东阳光药业股份有限公司 2024-04-16 CN claimed
WO-2014167530-A1 CANNABINOID COMPOUNDS BOWDEN MATTHEW JAMES (NZ) 2014-10-16 WO claimed
US-6376493-B1 SELECTIVE INHIBITION OF PHOSPHODIESTERASE IV AND TUMOR NECROSIS FACTOR; USEFUL IN TREATING OSTEOPOROSIS, TUMORS, AUTOIMMUNE DISEASES, RHEUMATIC DISEASES, AND ASTHMA MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2002-04-23 US claimed
EP-0353053-B1 Catalytic process for producing optically active alpha-hydroxycarboxylates TAKASAGO PERFUMERY CO LTD (JP) 1993-10-20 EP claimed
US-4965398-A Process for producing optically active alpha-hydroxycarboxylates TAKASAGO INTERNATIONAL CORPORATION (JP) 1990-10-23 US claimed
EP-0353053-A2 Catalytic process for producing optically active alpha-hydroxycarboxylates Takasago International Corporation (JP) 1990-01-31 EP claimed
CN-117886814-A PD-1/PD-L1 small molecule inhibitor and application thereof in medicines 广东东阳光药业股份有限公司 2024-04-16 CN disclosed
WO-2024043341-A1 CYCLOALKYNE DERIVATIVE ペプチドリーム株式会社 2024-02-29 WO disclosed
CN-117420238-A Method for identifying fingered citron production place 暨南大学 2024-01-19 CN disclosed
CN-110769821-A Spirocyclic indolines as IL-17 modulators UCB生物制药私人有限公司 2020-02-07 CN disclosed
EP-2216312-B1 PROCESS FOR PRODUCING ORGANIC COMPOUND M TECHNIQUE CO LTD (JP) 2019-05-01 EP disclosed
CN-105874153-B Modified hydrocarbon resins as fluid loss additives 佐治亚-太平洋化工品有限公司 2019-04-30 CN disclosed
US-10005947-B2 Modified hydrocarbon resins as fluid loss additives INGEVITY SOUTH CAROLINA, LLC (US) 2018-06-26 US disclosed
US-4965398-A Process for producing optically active alpha-hydroxycarboxylates TAKASAGO INTERNATIONAL CORPORATION (JP) 1990-10-23 US disclosed
EP-0353053-A2 Catalytic process for producing optically active alpha-hydroxycarboxylates Takasago International Corporation (JP) 1990-01-31 EP disclosed
EP-0349195-A2 Direct synthesis by cationic polymerization of nitrogen-containing polymers EXXON CHEMICAL PATENTS INC. (US) 1990-01-03 EP disclosed
US-4604480-A USING 1-HALOALKYL-1-SULFONYL HALIDE THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1986-08-05 US disclosed
US-4495188-A HYPERTENSIVE AGENT SANKYO COMPANY LIMITED (JP) 1985-01-22 US disclosed
US-4433100-A DICYCLOPENTADIENE, NON-AROMATIC UNSATURATED HYDROCARBON, FATTY OR ROSIN ACID NEVILLE CHEMICAL COMPANY (US) 1984-02-21 US disclosed
EP-0053047-A1 Acylaminoquinazoline derivatives, a process for their preparation and a pharmaceutical composition containing them SANKYO COMPANY LIMITED (JP) 1982-06-02 EP disclosed